BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
ECPG
Encore Capital Group, Inc.
ECPG has the edge over BAC overall, supported by stronger fundamentals and stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ECPG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ECPG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ECPG.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over ECPG in the historical PE scenario, which offers more potential upside but is not a forecast.
ECPG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.4x | $68.62 | -38% |
| Fair | 6.2x | $96.38 | -12% |
| Forward | 6.8x | $110 | — |
| Current | 7.1x | $110 | — |
| Expensive | 11x | $164 | +49% |
Historical ranges are pointers, not guarantees.
ECPG's PE is in its expensive range at 7.1x. If earnings grow as analysts expect, today's price would be 6.8x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over ECPG on the outlook, with more favorable valuation expectations.
ECPG Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for ECPG, with profitability improving. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
ECPG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $16.12 | +3.6% |
| Q3 2026 | $15.56 | +$17.35 |
| Q2 2026 | $13.16 | +$16.86 |
| Q1 2026 | $12.84 | +$17.69 |
| Q4 2025 | $10.91 | +$16.74 |
| Q3 2025 | -$1.79 | +$6.00 |
| Q2 2025 | -$3.70 | +$4.56 |
| Q1 2025 | -$4.85 | +$3.67 |
| Q4 2024 | -$5.83 | +$2.89 |
ECPG has returned to profit: it earned $15.56 per share over the past year, after losing money the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
ECPG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $544.5M | +18% |
| Q2 2026 | $491.9M | +11% |
| Q1 2026 | $475.4M | +21% |
| Q4 2025 | $473.6M | +78% |
| Q3 2025 | $460.4M | +25% |
| Q2 2025 | $442.1M | +24% |
| Q1 2025 | $392.8M | +20% |
| Q4 2024 | $265.6M | -4.2% |
ECPG's revenue has grown year over year for seven quarters in a row: $545M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 42% | +4.7 points |
| Q2 2026 | 38% | +3.9 points |
| Q1 2026 | 39% | +5.8 points |
| Q4 2025 | 37% | +87 points |
| Q3 2025 | 38% | +8.7 points |
| Q2 2025 | 34% | +5.4 points |
| Q1 2025 | 33% | +7.5 points |
| Q4 2024 | -51% | +28 points |
ECPG has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over ECPG on cash flow, with more consistent year-over-year improvement.
ECPG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $101.9M | +35% |
| Q2 2026 | -$37.8M | -1283% |
| Q1 2026 | $77.5M | +102% |
| Q4 2025 | $9.9M | -34% |
| Q3 2025 | $75.6M | +90% |
| Q2 2025 | $3.2M | -89% |
| Q1 2025 | $38.3M | -13% |
| Q4 2024 | $15M | -48% |
ECPG's free cash flow was $151M over the past year, up 15% from the year before. Free cash flow isn't a meaningful measure for financial services companies like ECPG.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ECPG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.4% | -536K shares |
| 1 year | -5.4% | -1.3M shares |
| 3 years | -8.7% | -2.1M shares |
| 5 years | -29% | -9.2M shares |
| Available history | -29% | -9.2M shares |
ECPG has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | $25.6M |
| Q4 2022 | $10.4M |
| Q3 2022 | $25.9M |
| Q2 2022 | $25.1M |
| Q1 2022 | $25.7M |
| Q4 2021 | $302.5M |
| Q3 2021 | $40.7M |
| Q2 2021 | $27M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ECPG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 5.9x | High |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | 18.5x | High |
ECPG has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ECPG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.4 | Neutral |
| Stochastic | 58.7 | Neutral |
ECPG's weekly RSI is 68 (neutral) and its Stochastic is 59 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
ECPG PE vs Financial Services Sector
| Metric | ECPG | Sector median | Relative |
|---|---|---|---|
| PE | 7.1x | 13x | 46% below |
| PE % | 67 | 63 | 4 pts above |
ECPG has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ECPG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $102.2 | 7.5% above |
| 20 week MA | $98.8 | 11% above |
| 50 week MA | $80.9 | 36% above |
| 100 week MA | $61.2 | 79% above |
| 200 week MA | $54.5 | 101% above |
ECPG has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
ECPG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.0 | $37.8 | +5.1% |
| 2021 | $37.8 | $60.2 | +59% |
| 2022 | $60.2 | $47.2 | -22% |
| 2023 | $47.2 | $50.8 | +7.6% |
| 2024 | $50.8 | $47.5 | -6.4% |
| 2025 | $47.5 | $55.5 | +17% |
| 2026 YTD | $55.5 | $109.9 | +98% |
ECPG has the edge over BAC on returns for 2026, with the stronger performance.